What Is Eosinophilic Asthma? Diagnosis, Causes, Complications, and Treatment
What Is Eosinophilic Asthma?
Asthma is a condition in which airway inflammation makes it hard to breathe. This can result from allergic and nonallergic causes.
“Asthma is characterized by airflow obstruction and limitation of airflow that’s associated with inflammation,” says Michael Wechsler, MD, a codirector of the Cohen Family Asthma Institute at National Jewish Health in Denver. “There’s a subset of asthma patients in whom that inflammation is caused by eosinophils.”
Causes and Risk Factors
- An allergic reaction
- A parasitic disease
- A drug reaction
- Genetic factors
- Stress
- Exposure to pollutants
- A respiratory infection
Eos Asthma and Other Asthma Types
Eos asthma can resemble other types of asthma, but there are also differences.
Age
Allergies
Symptoms
Response to Treatment
Type 2 asthma, such as eos asthma, responds to inhaled corticosteroids and biologic drugs. Non–type 2 asthma may not respond to these drugs.
Symptoms of Eosinophilic Asthma
The symptoms of eosinophilic asthma can resemble those of other asthma types, but there may be additional symptoms.
- Wheezing
- Coughing
- Shortness of breath or breathing difficulty
- Chest tightness
- Airflow obstruction, affecting how well the lungs work
- Persistent rhinosinusitis
- Nasal polyps
- Inflamed mucous membrane in the nose
Diagnosis of Eosinophilic Asthma
- Your symptoms
- Any history of asthma
- Any allergies
- Other medical history
They will also carry out a physical examination.
If the doctor suspects eos asthma, they may also do tests to see if you have high levels of eosinophils.
Tests for Eos Asthma
- A blood test: A health professional will use a needle to take a small blood sample, usually in a doctor’s office. They’ll then send it to a laboratory for testing. Eosinophil levels of 150 cells per microgram (mcg) or over may be a sign of eos asthma.
- A sputum test: You’ll need to cough up a mucus sample, usually in a doctor’s office. Your doctor will send it to a pathologist to examine under a microscope. An eosinophil count of 2 percent or higher in sputum may indicate eos asthma.
- A bronchial biopsy: A specialist lung doctor (pulmonologist) will apply local anesthesia and put a narrow tube (bronchoscope) down your throat and into your lungs. The device will collect small samples of tissue and fluid. The doctor will examine this to see if the samples contain eosinophils. You may need to do this in a hospital.
Dr. Wechsler notes: “It’s really important for people with severe asthma to ask, 'What kind of asthma do I have? Do I have eosinophils? What is the subtype of asthma?'” He adds, “New treatments released over the past three years can help with the eosinophilic subtype.”
The right diagnosis will help you get the right treatment.
Treatment and Management of Eosinophilic Asthma
Common Asthma Drugs That May Help
- Bronchodilators, which relax and open the airways
- Corticosteroids and other anti-inflammatory medications
- Options combining both bronchodilators and anti-inflammatory drugs
Long-Term Drugs and Biologics for Eos Asthma
If the usual asthma drugs don’t help, your doctor may suggest other long-acting options such as leukotriene modifiers or a biologic drug.
Leukotriene Modifiers
Leukotriene modifiers block the action of leukotrienes and stop these symptoms from happening. They can help with various types of asthma.
- montelukast (Singulair)
- zafirlukast (Accolate)
- zileuton (Zyflo)
Biologics
- benralizumab (Fasenra): Delivered as an injection, you can use this drug from the age of 12 years. It reduces inflammation by lowering eosinophil levels.
- mepolizumab (Nucala): Also delivered as a shot, this is suitable for those 6 years and older. It reduces eosinophil levels, which decreases inflammation.
- reslizumab (Cinqair): This intravenous drug is suitable for people with eos asthma aged 18 or above. It lowers eosinophil levels and reduces inflammation.
- dupilumab (Dupixent): Delivered as a shot, this drug helps reduce flares in people aged 6 and over with moderate to severe eos asthma or oral corticosteroid-dependent asthma. It can also help manage severe eczema (atopic dermatitis) and chronic sinusitis with nasal polyposis.
According to Wechsler, “This treatment doesn’t necessarily eliminate attacks or exacerbations, but in some people it does, and in other people it reduces them dramatically.”
Complications of Eosinophilic Asthma
Eosinophilic asthma can lead to complications. It can also occur with or possibly increase the risk of other conditions.
- Nasal polyps
- Persistent sinusitis, rhinitis, or both, known as rhinosinusitis
- Aspirin-exacerbated respiratory disease (AERD) due to a higher sensitivity to aspirin
- Sensitivity to other nonsteroidal anti-inflammatory drugs (NSAIDs)
Early treatment for eos asthma may reduce the risk of complications.
Living With Eosinophilic Asthma
Eosinophilic asthma can be challenging, but medication and lifestyle choices can help you manage it.
- Find a specialist doctor you can trust. You may need an allergist, pulmonologist, or both. The American College of Allergy, Asthma & Immunology has an allergist locator on their website to help you find specialist care, and Apfed has one for a range of specialties.
- With your doctor, work out a treatment plan and follow it carefully. This includes finding the right medication, using it correctly, and attending follow-up visits.
- Learn more about eosinophilic asthma. The more you know about your condition, the more in control and less anxious you'll feel. For instance, you can sign up for a newsletter from dedicated sites such as Apfed.
- Keep a log of your symptoms and use it to pinpoint any triggers. Then do your best to avoid them.
- Speak with loved ones or seek counseling if living with eos asthma is causing anxiety, depression, or otherwise affecting your mental well-being.
The Takeaway
- Eosinophilic asthma, also called eos asthma, is a type of asthma that can happen when you have too many eosinophils, a type of white blood cell, in your airways.
- Eosinophils help protect the body from infections and other invaders, but too many can result in an overactive immune response and persistent inflammation.
- This form of asthma can be severe, and treatment is essential. Early treatment can prevent long-term damage and complications.
- Eos asthma symptoms don’t always respond to the usual asthma treatments. If so, biologic or leukotriene therapy can often help manage this condition.
Resources We Trust
- Cleveland Clinic: Eosinophils
- Asthma and Allergy Foundation of America: Understanding Eosinophilic Asthma
- EOS Asthma Toolkit: Living With Eos Asthma
- Mayo Clinic: Asthma Medications — Know Your Options
- American Partnership for Eosinophilic Disorders: Eosinophilic Asthma

Jon E. Stahlman, MD
Medical Reviewer
Jon E. Stahlman, MD, has been a practicing allergist for more than 25 years. He is currently the section chief of allergy and immunology at Children’s Healthcare of Atlanta's Scottish Rite campus and the senior physician at The Allergy & Asthma Center in Atlanta. He served as the president of the Georgia Allergy Society, has been named a Castle Connolly Top Doctor, and was listed as a Top Doctor by Atlanta magazine. His research interests include new therapies for asthma and allergic rhinitis as well as the use of computerized monitoring of lung function.
He received his bachelor's and medical degrees from Emory University. He completed his pediatric residency at Boston Children’s Hospital and his fellowship in allergy and clinical immunology at Harvard University’s Boston Children’s Hospital and Brigham and Women’s Hospital. After his training, Dr. Stahlman conducted two years of clinical research at Boston Children’s Hospital and was part of the faculty at Harvard Medical School, where he taught medical students and allergy and immunology fellows.
Stahlman is board-certified and recertified in allergy and clinical immunology. He served as a principal investigator on phase 2 through 4 studies that are responsible for most of the U.S. Food and Drug Administration–approved therapies for allergies and asthma available today.
Outside of the office, he centers his interests around his wife and three daughters, coaching soccer for many years, and his hobbies include cycling and triathlons.

Yvette Brazier
Author
Yvette Brazier's career has focused on language, communication, and content production, particularly in health education and information. From 2005 to 2015, she supported learning in the health science department of a higher education establishment, teaching the language of health, research, and other language application skills to paramedic, pharmacy, and medical imaging students.
From 2015 to 2023, Yvette worked as a health information editor at Medical News Today and Healthline. Yvette is now a freelance writer and editor, preparing content for Everyday Health, Medical News Today, and other health information providers.
- Understanding Eosinophilic Asthma. Asthma and Allergy Foundation of America. May 2024.
- About Eosinophilic Asthma. ESO Asthma Toolkit.
- Bakakos A et al. Severe Eosinophilic Asthma. Journal of Clinical Medicine. 2019.
- Eosinophils. Cleveland Clinic. May 2022.
- Weschler ME et al. Eosinophils in Health and Disease: A State-of-the-Art Review. Mayo Clinic Proceedings. October 2021.
- Inflammation. Cleveland Clinic. March 2024.
- Kanda A et al. The Multiple Functions and Subfunctions of Eosinophils in Tissues Under Steady-State and Pathological Conditions. Allergology International. January 2021.
- Severe Asthma. American Lung Association.
- Hussain M et al. Eosinophilic Asthma: Pathophysiology and Therapeutic Horizons. Cells. February 2024.
- Eosinophilic Asthma. American Partnership for Eosinophilic Disorders. March 2020.
- Severe Asthma. American Lung Association. November 2024.
- Tashkin DP et al. Role of Eosinophils in Airway Inflammation of Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease. January 2018.
- Eosinophilic Asthma Diagnosis and Treatment. EOS Asthma Toolkit.
- Asthma Medications: Know Your Options. Mayo Clinic. July 2024.
- Leukotriend Modifiers. Cleveland Clinic. June 2021.
- Sidiqqi S et al. Eosinophils and Tissue Remodeling: Relevance to Airway Disease. Journal of Allergy and Clinical Immunology. October 2023.
- Living With Eos Asthma. EOS Asthma Toolkit.
- Research and Clinical Trials. EOS Asthma Toolkit.